跳至主要内容
临床试验/NCT01728896
NCT01728896已完成不适用

A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis

University of Auckland, New Zealand1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2013年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
56
试验地点
1
主要终点
Oral food intolerance

研究概览

简要总结

The first step in treating patients with acute pancreatitis is to provide pain relief and intravenous fluids to keep them comfortable. As the pain subsides and patient starts to feel better food and fluids by mouth are restarted. This is done to rest the pancreas which is the organ that has been inflamed.

In some patients when food by mouth restarts they have pain and as a consequence they have a longer stay in hospital. It is thought that patients who have little pain and are within 24 hours of admission to hospital do well if they control their own food intake. This is in contrast to the usual treatment where the treating team advise when eating should restart.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of acute pancreatitis
  • age > 18 years
  • written informed consent

排除标准

  • ongoing need for opiates
  • >96 hours after onset of symptoms
  • chronic pancreatitis
  • post-ERCP pancreatitis
  • intraoperative diagnosis
  • pregnancy
  • malignancy
  • received nutrition before randomisation

研究组 & 干预措施

Patient-controlled oral refeeding

Experimental

Patients will be allowed to drink and eat hospital food freely as tolerated.

干预措施: Patient-controlled oral refeeding (Other)

Conventional management

No Intervention

结局指标

主要结局

Oral food intolerance

时间窗: Participants will be followed for the duration of hospital stay, an expected average of 7 days

次要结局

  • Time from admission until tolerance of oral food(Participants will be followed for the duration of hospital stay, an expected average of 7 days)
  • Change in plasma C-reactive protein(Baseline and 24, 48, 72h after randomisation)
  • Need for opiates(Participants will be followed for the duration of hospital stay, an expected average of 7 days)
  • Hospital readmission(2 weeks after hospital discharge)
  • Total length of hospital stay(Participants will be followed for the duration of hospital stay, an expected average of 7 days)
  • Change in pain intensity(Baseline and 24, 48, 72h after randomisation)
  • Progression of acute pancreatitis severity(Participants will be followed for the duration of hospital stay, an expected average of 7 days)
  • Local and systemic complications(Participants will be followed for the duration of hospital stay, an expected average of 7 days)
  • Time from admission until first flatus(Participants will be followed for the duration of hospital stay, an expected average of 7 days)
  • Change in blood glucose(Baseline and 24, 48, 72h after randomisation)
  • Number and type of interventions during hospital stay(Participants will be followed for the duration of hospital stay, an expected average of 7 days)

研究者

发起方
University of Auckland, New Zealand
申办方类型
Other
责任方
Principal Investigator
主要研究者

Max Petrov

Prinicpal Investigator Dr. Max Petrov

University of Auckland, New Zealand

研究点 (1)

Loading locations...

相似试验